Sindrome.del.Ovario.Poliquistico

Fecundación in vitro 163
44
Van Santbrink EJ, Fauser BC. Urinary
follicle-stimulating hormone for normogonadotropic
clomiphene-resistant
anovulatory infertility: prospective,
randomized comparison between low
dose step-up and step-down dose regimens.
J Clin Endocrinol Metab. 1997;82:
3597-602.
45
Simón C, García Velasco JA, Valbuena
D, Peinado JA, Moreno C, Remohí J,
et al. Increasing uterine receptivity by
decreasing estradiol levels during the
preimplantation period in high responders
with the use of a follicle-stimulating
hormone step-down regimen. Fertil
Steril. 1998;70:234-9.
46
Dor J, Shulman A, Levran D, Ben-
Rafael Z, Rudak E, Mashiach S. The
treatment of patients with polycystic
ovarian syndrome by in-vitro fertilization
and embryo transfer: a comparison
of results with those of patients with
tubal infertility. Hum Reprod. 1990;5:
816-8.
47
Mulders AG, Laven JS, Imani B, Eijkemans
MJ, Fauser BC. IVF outcome
in anovulatory infertility (WHO group
2)-including polycystic ovary syndromefollowing
previous unsuccessful ovulation
induction. Reprod Biomed Online.
2003;7:50-8.
48
Ludwig M, Finas DF, Al-Hasani S, Diedrich
K, Ortmann O. Oocyte quality
and treatment outcome in intracytoplasmic
sperm injection cycles of polycystic
ovarian syndrome patients. Hum
Reprod. 1999;14:354-8.
49
Lessing JB, Amit A, Libal Y, Yovel I,
Kogosowski A, Peyser MR. Avoidance of
cancellation of potential hyperstimulation
cycles by conversion to in vitro fertilization-embryo
transfer. Fertil Steril.
1991;56:75-8.
50
Fedorcsák P, Dale PO, Storeng R, Tanbo
T, Abyholm T. The impact of obesity
and insulin resistance on the outcome
of IVF or ICSI in women with polycystic
ovarian syndrome. Hum Reprod.
2001;16:1086-91.
51
Enskog A, Henriksson M, Unander M,
Nilsson L, Brannstrom M. Prospective
study of the clinical and laboratory
parameters of patients in whom ovarian
hyperstimulation syndrome developed
during controlled ovarian hyperstimulation
for in vitro fertilization. Fertil Steril.
1999;71:808-14.
52
Pellicer A, Albert C, Mercader A, Bonilla-
Musoles F, Remohí J, Simón C. The
pathogenesis of ovarian hyperstimulation
syndrome: in vivo studies investigating
the role of interleukin-1beta,
interleukin-6, and vascular endothelial
growth factor. Fertil Steril. 1999;71:
482-9.
53
Chen D, Burmeister L, Goldschlag D,
Rosenwaks Z. Ovarian hyperstimulation
syndrome: strategies for prevention.
Reprod Biomed Online. 2003;7:43-9.
54
Muñoz E, Ramírez A, Bellver J, Pellicer
A, Remohí J. Síndrome de hiperestimulación
ovárica. En: Remohí J, Cobo A,
Romero JL, Pellicer A, Simón C, editores.
Manual práctico de esterilidad y reproducción
humana. Madrid: Interamericana;
2004. p. 172-88.
55
Aboulghar MA, Mansour RT. Ovarian
hyperstimulation syndrome: classifications
and critical analysis of preventive
measures. Hum Reprod Update. 2003;
9:275-89.
56
Child TJ, Abdul-Jalil AK, Gulekli B, Tan
SL. In vitro maturation and fertilization
of oocytes from unstimulated normal
ovaries, polycystic ovaries, and women
with polycystic ovary syndrome. Fertil
Steril. 2001;76:936-42.
57
Whelan JG, Vlahos NF. The ovarian
hyperstimulation syndrome. Fertil Steril.
2000;73:883-96.
58
The Practice Committee of the American
Society for Reproductive Medicine.
Ovaryan hyperstimulation syndrome.
Fertil Steril. 2003;80:1309-14.
59
Cano F, García-Velasco JA, Millet A,
Remohí J, Simón C, Pellicer A. Oocyte
quality in polycystic ovaries revisited:
Identification of a particular subgroup of